NO20003640D0 - Ny doseringsform - Google Patents

Ny doseringsform

Info

Publication number
NO20003640D0
NO20003640D0 NO20003640A NO20003640A NO20003640D0 NO 20003640 D0 NO20003640 D0 NO 20003640D0 NO 20003640 A NO20003640 A NO 20003640A NO 20003640 A NO20003640 A NO 20003640A NO 20003640 D0 NO20003640 D0 NO 20003640D0
Authority
NO
Norway
Prior art keywords
dosage form
new dosage
new
dosage
Prior art date
Application number
NO20003640A
Other languages
English (en)
Other versions
NO20003640L (no
Inventor
Peter Watts
Lisbeth Illum
Original Assignee
West Pharm Serv Drug Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by West Pharm Serv Drug Res Ltd filed Critical West Pharm Serv Drug Res Ltd
Publication of NO20003640D0 publication Critical patent/NO20003640D0/no
Publication of NO20003640L publication Critical patent/NO20003640L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
NO20003640A 1998-01-22 2000-07-14 Ny doseringsform NO20003640L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9801363.4A GB9801363D0 (en) 1998-01-22 1998-01-22 Novel dosage form
PCT/GB1999/000193 WO1999037290A1 (en) 1998-01-22 1999-01-20 Novel dosage form

Publications (2)

Publication Number Publication Date
NO20003640D0 true NO20003640D0 (no) 2000-07-14
NO20003640L NO20003640L (no) 2000-09-12

Family

ID=10825713

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003640A NO20003640L (no) 1998-01-22 2000-07-14 Ny doseringsform

Country Status (9)

Country Link
EP (1) EP1059918A1 (no)
JP (1) JP2002501016A (no)
AR (1) AR014467A1 (no)
AU (1) AU2176099A (no)
CA (1) CA2318257A1 (no)
GB (1) GB9801363D0 (no)
NO (1) NO20003640L (no)
WO (1) WO1999037290A1 (no)
ZA (1) ZA99454B (no)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9910773D0 (en) * 1999-05-11 1999-07-07 West Pharm Serv Drug Res Ltd Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
WO2006020009A1 (en) * 2004-07-23 2006-02-23 The Procter & Gamble Company Solid oral dosage form of a bisphosphonate containing a chelating agent
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
CN105468895A (zh) 2006-05-02 2016-04-06 普罗透斯数字保健公司 患者定制的治疗方案
EP2083680B1 (en) 2006-10-25 2016-08-10 Proteus Digital Health, Inc. Controlled activation ingestible identifier
EP2069004A4 (en) 2006-11-20 2014-07-09 Proteus Digital Health Inc PERSONAL HEALTH SIGNAL RECEIVERS WITH ACTIVE SIGNAL PROCESSING
MY165532A (en) 2007-02-01 2018-04-02 Proteus Digital Health Inc Ingestible event marker systems
CA2676280C (en) 2007-02-14 2018-05-22 Proteus Biomedical, Inc. In-body power source having high surface area electrode
EP2124725A1 (en) 2007-03-09 2009-12-02 Proteus Biomedical, Inc. In-body device having a multi-directional transmitter
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US8540632B2 (en) 2007-05-24 2013-09-24 Proteus Digital Health, Inc. Low profile antenna for in body device
DK2192946T3 (da) 2007-09-25 2022-11-21 Otsuka Pharma Co Ltd Kropsintern anordning med virtuel dipol signalforstærkning
ES2661739T3 (es) 2007-11-27 2018-04-03 Proteus Digital Health, Inc. Sistemas de comunicación transcorporal que emplean canales de comunicación
MY161533A (en) 2008-03-05 2017-04-28 Proteus Digital Health Inc Multi-mode communication ingestible event markers and systems, and methods of using the same
SG195535A1 (en) 2008-07-08 2013-12-30 Proteus Digital Health Inc Ingestible event marker data framework
KR101214453B1 (ko) 2008-08-13 2012-12-24 프로테우스 디지털 헬스, 인코포레이티드 복용 가능한 회로
AU2010203625A1 (en) 2009-01-06 2011-07-21 Proteus Digital Health, Inc. Ingestion-related biofeedback and personalized medical therapy method and system
WO2010111403A2 (en) 2009-03-25 2010-09-30 Proteus Biomedical, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
CN102458236B (zh) 2009-04-28 2016-01-27 普罗秋斯数字健康公司 高可靠性的可摄入事件标记器及其使用方法
WO2010132331A2 (en) 2009-05-12 2010-11-18 Proteus Biomedical, Inc. Ingestible event markers comprising an ingestible component
TWI517050B (zh) 2009-11-04 2016-01-11 普羅托斯數位健康公司 供應鏈管理之系統
WO2011127252A2 (en) 2010-04-07 2011-10-13 Proteus Biomedical, Inc. Miniature ingestible device
TWI557672B (zh) 2010-05-19 2016-11-11 波提亞斯數位康健公司 用於從製造商跟蹤藥物直到患者之電腦系統及電腦實施之方法、用於確認將藥物給予患者的設備及方法、患者介面裝置
JP2014504902A (ja) 2010-11-22 2014-02-27 プロテウス デジタル ヘルス， インコーポレイテッド 医薬品を有する摂取可能なデバイス
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
BR112014001397A2 (pt) 2011-07-21 2017-02-21 Proteus Biomedical Inc dispositivo, sistema e método de comunicação móvel
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
WO2014018454A1 (en) 2012-07-23 2014-01-30 Proteus Digital Health, Inc. Techniques for manufacturing ingestible event markers comprising an ingestible component
JP5869736B2 (ja) 2012-10-18 2016-02-24 プロテウス デジタル ヘルス， インコーポレイテッド 通信デバイス用の電源において電力消失およびブロードキャスト電力を適応的に最適化するための装置、システム、および方法
TWI659994B (zh) 2013-01-29 2019-05-21 美商普羅托斯數位健康公司 高度可膨脹之聚合型薄膜及包含彼之組成物
JP5941240B2 (ja) 2013-03-15 2016-06-29 プロテウス デジタル ヘルス， インコーポレイテッド 金属検出器装置、システム、および方法
JP6511439B2 (ja) 2013-06-04 2019-05-15 プロテウス デジタル ヘルス， インコーポレイテッド データ収集および転帰の査定のためのシステム、装置、および方法
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
KR20210018961A (ko) 2016-07-22 2021-02-18 프로테우스 디지털 헬스, 인코포레이티드 섭취 가능한 이벤트 마커의 전자기 감지 및 검출
IL265827B2 (en) 2016-10-26 2023-03-01 Proteus Digital Health Inc Methods for producing capsules with ingestible event markers
US11458104B1 (en) * 2018-06-21 2022-10-04 Mission Pharmacal Company Enteric coated tiopronin tablet
CN109453166B (zh) * 2018-10-16 2021-03-12 丹诺医药(苏州）有限公司 一种利福霉素-喹嗪酮偶联分子的固体分散体及其应用
CN110613697A (zh) * 2019-10-30 2019-12-27 长春迪瑞制药有限公司 一种头孢氨苄胶囊及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786508A (en) * 1986-05-30 1988-11-22 Warner-Lambert Company Coated dosage forms
FR2618331B1 (fr) * 1987-07-23 1991-10-04 Synthelabo Compositions pharmaceutiques utiles pour le traitement de l'uremie
AU618589B2 (en) * 1988-04-05 1992-01-02 Kyowa Hakko Kogyo Co. Ltd. Oral compositions for ruminants

Also Published As

Publication number Publication date
AU2176099A (en) 1999-08-09
EP1059918A1 (en) 2000-12-20
CA2318257A1 (en) 1999-07-29
ZA99454B (en) 2000-10-23
JP2002501016A (ja) 2002-01-15
GB9801363D0 (en) 1998-03-18
WO1999037290A1 (en) 1999-07-29
AR014467A1 (es) 2001-02-28
NO20003640L (no) 2000-09-12

Similar Documents

Publication Publication Date Title
NO20003640D0 (no) Ny doseringsform
ATE321483T1 (de) Dose
NO20005503D0 (no) Ny anvendelse
NO992692D0 (no) Nefadozon doseringsform
NO20012915L (no) Ny farmasöytisk formulering
ATE392890T1 (de) Hydrogel-gesteuerte dosierungsform
NO20021116D0 (no) Ny sammensetning
NO20005913D0 (no) Legemiddelsammensetning
NO20004773D0 (no) Forlenget-frigjøringsblandinger
DE69930866D1 (de) Dosiervorrichtung
NO991944D0 (no) Ny forbindelse
NO20021115L (no) Ny sammensetning
NO20003996D0 (no) Ny forbindelse
EE200000022A (et) Uus ravimvorm
DE69921275D1 (de) Inhalationsgerät
DK199901730A (da) Ny Sammensætning
DE29817592U1 (de) Dose
NO20005483D0 (no) Ny sammensetning
IS5877A (is) Ný efnablanda
IS5879A (is) Ný efnablanda
DE29821753U1 (de) Dose
DE29805919U1 (de) Formularsatz
SE9804020D0 (sv) New use
SE9801370D0 (sv) New use
SE9800472D0 (sv) New use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application